Twist Bioscience (TWST) Shares Outstanding (2017 - 2026)

Twist Bioscience (TWST) has reported Shares Outstanding (Entity) for 10 consecutive years, with $62.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 4.15% year-over-year to $62.7 million in Q2 2026; TTM through Jun 2026 was $62.7 million, a 4.15% increase from a year earlier, with the FY2025 full-year figure at $60.6 million, up 2.98% from the prior year.
• Shares Outstanding (Entity) was $62.7 million for Q2 2026 at Twist Bioscience, up from $62.2 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $62.7 million in Q2 2026 and troughed at $56.2 million in Q1 2022.
• A 5-year average of $58.7 million and a median of $58.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) increased 15.09% in 2022 and rose 1.55% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $56.6 million in 2022, then increased by 2.0% to $57.8 million in 2023, then advanced by 3.12% to $59.6 million in 2024, then increased by 2.84% to $61.3 million in 2025, then grew by 2.28% to $62.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $62.7 million (Q2 2026), $62.2 million (Q1 2026), and $61.3 million (Q4 2025), per Business Quant data.